In The Cancer Genome Atlas (TCGA) dataset, 14% of invasive bladder cancers have mutations in CDKN1A encoding the cyclin-dependent kinase inhibitor p21CIP1 [24]. Here, CDKN1A is linked to urinary bladder carcinoma.